Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
3,325,529
-
Shares change
-
-727,581
-
Total reported value, excl. options
-
$9,074,596
-
Value change
-
-$2,104,345
-
Put/Call ratio
-
69.67%
-
Number of buys
-
24
-
Number of sells
-
-33
-
Price
-
$2.73
Significant Holders of GALECTIN THERAPEUTICS INC - COM NEW (GALT) as of Q2 2015
70 filings reported holding GALT - GALECTIN THERAPEUTICS INC - COM NEW as of Q2 2015.
GALECTIN THERAPEUTICS INC - COM NEW (GALT) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,325,529 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (579,973 shares), Cormorant Asset Management, LLC (286,200 shares), SPHERA FUNDS MANAGEMENT LTD. (205,000 shares), AMERICAN INTERNATIONAL GROUP INC (193,625 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (183,931 shares), NORTHERN TRUST CORP (182,477 shares), Neuberger Berman Group LLC (154,662 shares), DAVIDSON D A & CO (141,581 shares), D. E. Shaw & Co., Inc. (140,753 shares), and GEODE CAPITAL MANAGEMENT, LLC (99,851 shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.